Published in J Virol on August 01, 2005
Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution. J Virol (2007) 2.65
Molecular targets for flavivirus drug discovery. Antiviral Res (2008) 2.32
Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. EMBO J (2008) 1.99
Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res (2009) 1.87
Crystal structure of the NS3 protease-helicase from dengue virus. J Virol (2007) 1.84
Yellow Fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J Virol (2008) 1.59
Structural proteomics of dengue virus. Curr Opin Microbiol (2008) 1.57
Inhibition of dengue virus by targeting viral NS4B protein. J Virol (2011) 1.31
Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication. J Virol (2009) 1.29
Analysis of flavivirus NS5 methyltransferase cap binding. J Mol Biol (2008) 1.27
Conservation and variability of dengue virus proteins: implications for vaccine design. PLoS Negl Trop Dis (2008) 1.23
A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan. Genet Vaccines Ther (2012) 1.21
Flexibility between the protease and helicase domains of the dengue virus NS3 protein conferred by the linker region and its functional implications. J Biol Chem (2010) 1.14
Dengue virus nonstructural protein 5 adopts multiple conformations in solution. Biochemistry (2012) 1.07
Replication cycle and molecular biology of the West Nile virus. Viruses (2013) 1.03
Mapping protein interactions between Dengue virus and its human and insect hosts. PLoS Negl Trop Dis (2011) 1.03
Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis. J Virol (2007) 1.02
Structure-based mutational analysis of the NS3 helicase from dengue virus. J Virol (2006) 1.01
The C-terminal 50 amino acid residues of dengue NS3 protein are important for NS3-NS5 interaction and viral replication. J Biol Chem (2014) 1.01
Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor. Biochemistry (2010) 1.00
Structure of the Murray Valley encephalitis virus RNA helicase at 1.9 Angstrom resolution. Protein Sci (2007) 0.98
Crystal structure of the dengue virus methyltransferase bound to a 5'-capped octameric RNA. PLoS One (2010) 0.96
A translation inhibitor that suppresses dengue virus in vitro and in vivo. Antimicrob Agents Chemother (2011) 0.95
Novel ATP-independent RNA annealing activity of the dengue virus NS3 helicase. PLoS One (2012) 0.95
Focus on flaviviruses: current and future drug targets. Future Med Chem (2009) 0.94
The core protein of classical Swine Fever virus is dispensable for virus propagation in vitro. PLoS Pathog (2012) 0.91
Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase. Antimicrob Agents Chemother (2013) 0.91
NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus. Genet Mol Biol (2010) 0.90
Crystal structure of the superfamily 1 helicase from Tomato mosaic virus. J Virol (2012) 0.87
The crystal structure of Zika virus helicase: basis for antiviral drug design. Protein Cell (2016) 0.87
Illustrating and homology modeling the proteins of the Zika virus. F1000Res (2016) 0.86
Alfalfa mosaic virus coat protein bridges RNA and RNA-dependent RNA polymerase in vitro. Virology (2007) 0.86
Molecular modeling and pharmacophore elucidation study of the Classical Swine Fever virus helicase as a promising pharmacological target. PeerJ (2013) 0.86
Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation. Antiviral Res (2012) 0.86
Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines. PLoS One (2011) 0.86
High affinity human antibody fragments to dengue virus non-structural protein 3. PLoS Negl Trop Dis (2010) 0.85
Mapping the Interactions between the NS4B and NS3 proteins of dengue virus. J Virol (2015) 0.85
The acidic sequence of the NS4A cofactor regulates ATP hydrolysis by the HCV NS3 helicase. Arch Virol (2010) 0.82
Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme. PLoS One (2011) 0.82
Unzippers, resolvers and sensors: a structural and functional biochemistry tale of RNA helicases. Int J Mol Sci (2015) 0.81
Preliminary crystallographic characterization of an RNA helicase from Kunjin virus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.81
Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase. ACS Infect Dis (2015) 0.80
Synergistic interactions between the NS3(hel) and E proteins contribute to the virulence of dengue virus type 1. PLoS Negl Trop Dis (2012) 0.80
Flaviviral Replication Complex: Coordination between RNA Synthesis and 51-RNA Capping. Viruses (2015) 0.80
Predicting DNA-binding proteins and binding residues by complex structure prediction and application to human proteome. PLoS One (2014) 0.79
X-ray structure of the pestivirus NS3 helicase and its conformation in solution. J Virol (2015) 0.79
Synthetic 1,4-pyran naphthoquinones are potent inhibitors of dengue virus replication. PLoS One (2013) 0.79
Deciphering the molecular basis for nucleotide selection by the West Nile virus RNA helicase. Nucleic Acids Res (2010) 0.79
Structure of the NS3 helicase from Zika virus. Nat Struct Mol Biol (2016) 0.78
Steady-state NTPase activity of Dengue virus NS3: number of catalytic sites, nucleotide specificity and activation by ssRNA. PLoS One (2013) 0.78
A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease. Antimicrob Agents Chemother (2013) 0.77
Regulation of flavivirus RNA synthesis and capping. Wiley Interdiscip Rev RNA (2013) 0.76
A Proline-Rich N-Terminal Region of the Dengue Virus NS3 Is Crucial for Infectious Particle Production. J Virol (2016) 0.76
Clinical outcome and genetic differences within a monophyletic Dengue virus type 2 population. PLoS One (2015) 0.76
Apo B100 similarities to viral proteins suggest basis for LDL-DNA binding and transfection capacity. J Lipid Res (2010) 0.76
Drug discovery for the developing world: progress at the Novartis Institute for Tropical Diseases. Nat Rev Drug Discov (2015) 0.75
Endoplasmic Reticulum Protein SCAP Inhibits Dengue Virus NS2B3 Protease by Suppressing Its K27-Linked Polyubiquitylation. J Virol (2017) 0.75
Monomeric nature of dengue virus NS3 helicase and thermodynamic analysis of the interaction with single-stranded RNA. Nucleic Acids Res (2014) 0.75
Structural features of NS3 of Dengue virus serotypes 2 and 4 in solution and insight into RNA binding and the inhibitory role of quercetin. Acta Crystallogr D Struct Biol (2017) 0.75
The uncoupling of protease trans-cleavage and helicase activities in the pestivirus NS3. J Virol (2017) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol (2000) 57.88
Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J (1982) 38.14
Protein structure comparison by alignment of distance matrices. J Mol Biol (1993) 34.74
Dengue and dengue hemorrhagic fever. Clin Microbiol Rev (1998) 19.59
An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem (1979) 13.55
Preparation of selenomethionyl proteins for phase determination. Methods Enzymol (1997) 9.16
SOLVE and RESOLVE: automated structure solution and density modification. Methods Enzymol (2003) 6.96
Crystal structures of complexes of PcrA DNA helicase with a DNA substrate indicate an inchworm mechanism. Cell (1999) 6.84
Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure (1998) 5.83
Structure of the recA protein-ADP complex. Nature (1992) 5.33
Major domain swiveling revealed by the crystal structures of complexes of E. coli Rep helicase bound to single-stranded DNA and ADP. Cell (1997) 4.71
Crystal structure of a DExx box DNA helicase. Nature (1996) 4.69
Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J Virol (1997) 4.35
Helicase structure and mechanism. Curr Opin Struct Biol (2002) 4.29
Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol (1997) 3.80
A dissection of specific and non-specific protein-protein interfaces. J Mol Biol (2004) 3.77
RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria. J Virol (1993) 2.52
The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding. EMBO J (2002) 2.52
Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA. J Biol Chem (1998) 2.35
The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol (1999) 2.34
Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication. J Virol (1993) 2.25
Modularity and specialization in superfamily 1 and 2 helicases. J Bacteriol (2002) 2.14
Periodic cycles of RNA unwinding and pausing by hepatitis C virus NS3 helicase. Nature (2004) 2.10
Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J Biol Chem (2000) 2.00
The helicase from hepatitis C virus is active as an oligomer. J Biol Chem (1999) 1.80
The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently. J Biol Chem (2003) 1.61
Site-directed mutagenesis of motif III in PcrA helicase reveals a role in coupling ATP hydrolysis to strand separation. Nucleic Acids Res (1999) 1.60
Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein. Biochem Biophys Res Commun (1996) 1.57
Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication. J Virol (2001) 1.49
Expression, purification, and characterization of the RNA 5'-triphosphatase activity of dengue virus type 2 nonstructural protein 3. Virology (2002) 1.45
Crystal structure of Thermus thermophilus HB8 UvrB protein, a key enzyme of nucleotide excision repair. J Biochem (1999) 1.43
Assignment of the multifunctional NS3 protein of bovine viral diarrhea virus during RNA replication: an in vivo and in vitro study. J Virol (1999) 1.40
The interdomain region of dengue NS5 protein that binds to the viral helicase NS3 contains independently functional importin beta 1 and importin alpha/beta-recognized nuclear localization signals. J Biol Chem (2002) 1.31
Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme. J Virol (2001) 1.25
A point mutation abolishes the helicase but not the nucleoside triphosphatase activity of hepatitis C virus NS3 protein. J Virol (1997) 1.25
Identification and characterization of the RNA helicase activity of Japanese encephalitis virus NS3 protein. FEBS Lett (2000) 0.93
Role of the DExH motif of the Japanese encephalitis virus and hepatitis C virus NS3 proteins in the ATPase and RNA helicase activities. Virology (2000) 0.89
Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J (2004) 4.05
Genomic epidemiology of a dengue virus epidemic in urban Singapore. J Virol (2009) 2.74
Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution. J Virol (2007) 2.65
Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol (2006) 2.55
A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis (2007) 2.22
Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep (2010) 2.14
ISPyB: an information management system for synchrotron macromolecular crystallography. Bioinformatics (2011) 2.14
Early Dengue infection and outcome study (EDEN) - study design and preliminary findings. Ann Acad Med Singapore (2006) 2.12
Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus. Structure (2006) 2.05
Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. EMBO J (2008) 1.99
Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness. PLoS Negl Trop Dis (2008) 1.99
Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis (2007) 1.86
Crystal structure of the NS3 protease-helicase from dengue virus. J Virol (2007) 1.84
Ten years of dengue drug discovery: progress and prospects. Antiviral Res (2013) 1.84
The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes. PLoS Pathog (2011) 1.78
Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J Biol Chem (2005) 1.70
Conventional and unconventional mechanisms for capping viral mRNA. Nat Rev Microbiol (2011) 1.61
A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother (2009) 1.59
The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog (2010) 1.57
Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials. Mol Cancer Ther (2014) 1.56
The early clinical features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl Trop Dis (2011) 1.52
A method for full genome sequencing of all four serotypes of the dengue virus. J Virol Methods (2010) 1.48
The use of workflows in the design and implementation of complex experiments in macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2012) 1.46
Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol (2006) 1.44
Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha/beta-recognized nuclear localization sequences is integral to viral infection. Traffic (2007) 1.41
Dengue virus serotype infection specifies the activation of the unfolded protein response. Virol J (2007) 1.41
Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res (2008) 1.41
Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A (2011) 1.40
Small molecule inhibitors that selectively block dengue virus methyltransferase. J Biol Chem (2010) 1.40
The functional role of a conserved loop in EAL domain-based cyclic di-GMP-specific phosphodiesterase. J Bacteriol (2009) 1.39
Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA. J Gen Virol (2006) 1.36
The flavivirus polymerase as a target for drug discovery. Antiviral Res (2008) 1.36
Structure of the functional form of the mosquito larvicidal Cry4Aa toxin from Bacillus thuringiensis at a 2.8-angstrom resolution. J Bacteriol (2006) 1.35
The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J Virol (2009) 1.32
The interdomain region of dengue NS5 protein that binds to the viral helicase NS3 contains independently functional importin beta 1 and importin alpha/beta-recognized nuclear localization signals. J Biol Chem (2002) 1.31
Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead. Bioorg Med Chem Lett (2005) 1.30
Finding new medicines for flaviviral targets. Novartis Found Symp (2006) 1.29
Functional analysis of two cavities in flavivirus NS5 polymerase. J Biol Chem (2011) 1.28
Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antiviral Res (2007) 1.27
Antibodies targeting the PfRH1 binding domain inhibit invasion of Plasmodium falciparum merozoites. PLoS Pathog (2008) 1.27
Biochemical and structural analysis of Helix pomatia agglutinin. A hexameric lectin with a novel fold. J Biol Chem (2006) 1.25
Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection. Proc Natl Acad Sci U S A (2011) 1.24
Periodic re-emergence of endemic strains with strong epidemic potential-a proposed explanation for the 2004 Indonesian dengue epidemic. Infect Genet Evol (2007) 1.23
Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors. Bioorg Med Chem Lett (2005) 1.22
X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation. J Virol (2006) 1.22
M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth. Proc Natl Acad Sci U S A (2012) 1.21
Biochemical and genetic characterization of dengue virus methyltransferase. Virology (2010) 1.21
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone. J Med Chem (2009) 1.17
The crystal structure of the plexin-semaphorin-integrin domain/hybrid domain/I-EGF1 segment from the human integrin beta2 subunit at 1.8-A resolution. J Biol Chem (2005) 1.16
The structures of the PII proteins from the cyanobacteria Synechococcus sp. PCC 7942 and Synechocystis sp. PCC 6803. Acta Crystallogr D Biol Crystallogr (2003) 1.16
CRIM1 regulates the rate of processing and delivery of bone morphogenetic proteins to the cell surface. J Biol Chem (2003) 1.15
The nucleocapsid protein of coronavirus infectious bronchitis virus: crystal structure of its N-terminal domain and multimerization properties. Structure (2005) 1.15
Mutagenesis of the dengue virus type 2 NS5 methyltransferase domain. J Biol Chem (2008) 1.14
Flexibility between the protease and helicase domains of the dengue virus NS3 protein conferred by the linker region and its functional implications. J Biol Chem (2010) 1.14
Novel inhibitors of dengue virus methyltransferase: discovery by in vitro-driven virtual screening on a desktop computer grid. J Med Chem (2010) 1.13
Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex. PLoS Pathog (2011) 1.13
A structural hypothesis for the transition between bent and extended conformations of the leukocyte beta2 integrins. J Biol Chem (2007) 1.12
On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes. J Gen Virol (2009) 1.11
Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model. Antiviral Res (2011) 1.11
Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines. J Gen Virol (2008) 1.10
The role of TBK1 and IKKε in the expression and activation of Pellino 1. Biochem J (2011) 1.10
Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control. Eur J Immunol (2009) 1.08
A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease. Anal Biochem (2009) 1.03
Structure and catalytic mechanism of the thioesterase CalE7 in enediyne biosynthesis. J Biol Chem (2009) 1.03
DengueInfo: A web portal to dengue information resources. Infect Genet Evol (2007) 1.03
Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial. Antiviral Res (2012) 1.03
A scintillation proximity assay for dengue virus NS5 2'-O-methyltransferase-kinetic and inhibition analyses. Antiviral Res (2008) 1.03
A crystal structure of the dengue virus non-structural protein 5 (NS5) polymerase delineates interdomain amino acid residues that enhance its thermostability and de novo initiation activities. J Biol Chem (2013) 1.03
Structure-based mutational analysis of the NS3 helicase from dengue virus. J Virol (2006) 1.01
A multi-step strategy to obtain crystals of the dengue virus RNA-dependent RNA polymerase that diffract to high resolution. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 1.00
Products of the iterative polyketide synthases in 9- and 10-membered enediyne biosynthesis. Chem Commun (Camb) (2009) 0.98
Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells. Nucleic Acids Res (2006) 0.97
Conformational flexibility of the Dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor. J Virol (2013) 0.97
Higher catalytic efficiency of N-7-methylation is responsible for processive N-7 and 2'-O methyltransferase activity in dengue virus. Virology (2010) 0.97
Crystal structure of the acyltransferase domain of the iterative polyketide synthase in enediyne biosynthesis. J Biol Chem (2012) 0.97
Macro-to-micro structural proteomics: native source proteins for high-throughput crystallization. PLoS One (2012) 0.96
Crystal structure of the dengue virus methyltransferase bound to a 5'-capped octameric RNA. PLoS One (2010) 0.96
Structure of the N-terminal domain of Escherichia coli glutamine synthetase adenylyltransferase. Structure (2004) 0.96
N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase. J Med Chem (2009) 0.95